Hyalocytes: Essential vitreous cells in vitreoretinal health and disease

Takeshi Kita, Taiji Sakamoto, Tatsuro Ishibashi

Research output: Chapter in Book/Report/Conference proceedingChapter

15 Citations (Scopus)


Vitreoretinal interface diseases are common causes of vision loss or metamorphopsia in spite of recent advances in clinical ophthalmology including vitreoretinal surgery, pharmacological therapy such as anti-VEGF agents, and gene-mediated therapy. The vitreous is often used as a therapeutic place or platform for these therapies; therefore, more detailed knowledge about the environment of the vitreous is required.

Original languageEnglish
Title of host publicationVitreous
Subtitle of host publicationIn Health and Disease
PublisherSpringer New York
Number of pages14
ISBN (Electronic)9781493910861
ISBN (Print)9781493910854
Publication statusPublished - Jan 1 2014
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Hyalocytes: Essential vitreous cells in vitreoretinal health and disease'. Together they form a unique fingerprint.

Cite this